News

View our latest research stories.

December 11, 2017 Policy Watch

Burden of Opioid Epidemic Mapped in Massachusetts Using a Unique Dataset

Using a legislatively-mandated, integrated dataset, the Massachusetts Department of Public Health has published its first comprehensive look at the state’s opioid-related overdoses between 2011 and 2015. The dataset was created as part of 2015 “Chapter 55” legislation. It links information on an individual level across diverse state databases, including mental health data, jail and prison data, vital records, substance […]

November 27, 2017 Policy Watch

How To Talk and Write about Substance Use Disorder

News and feature stories about the opioid epidemic appear daily in a variety of media outlets. To draw interest, these outlets often using provocative language to describe substance use disorders and those affected by substance use across the country. The 2017 Associated Press Stylebook, however, now encourages journalists and the media to use person-first language such […]

November 13, 2017 Policy Watch

Insurers Make Historic Commitment to Improve Access and Quality of Treatment for Substance Use Disorders

In a groundbreaking announcement, 12 large insurers, covering over 240 million lives, pledged to adopt eight evidence-based “National Principles of Care” for the treatment of substance use disorder (SUD). The initiative is designed to improve care for the 21 million Americans who have an SUD, only 11% of whom receive any treatment at all. The […]

September 25, 2017 Policy Watch

Abuse Deterrent Opioids: A Hard Sell

One strategy to combat the opioid epidemic is to change the formulation of opioids to deter abuse. Reformulations can make opioids harder or less pleasant to inject, snort, or chew, thereby reducing common methods of abuse. Since 2010, the FDA has approved 10 opioid abuse deterrent formulations, which are considerably more expensive than regular brand […]

September 7, 2017 Policy Watch

Addressing Gaps in Evidence-Based Opioid Policy and Practice

Although evidence from health policy research should inform policymaking, researchers and policymakers don’t always communicate. A conference sponsored by the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) – a NIDA-funded Center of Excellence – and hosted by the Leonard Davis Institute of Health Economics (LDI) sought to […]

August 30, 2017 Research Highlights

Increased Opioid-Related Inpatient stays and ED Visits

A recent statistical brief from the Agency for Healthcare Research and Quality (AHRQ) provides valuable information regarding patient characteristics for opioid-related inpatient stays and emergency department (ED) visits in the US and within 44 states and the District of Columbia. The brief comes from AHRQ’s Healthcare Cost and Utilization Project (HCUP), which is the largest all-payer encounter-level collection […]

August 10, 2017 Research Highlights

Monetary Conversion Factors for Evaluating Substance Use Disorder Interventions: New Resource for Researchers

The National Institute on Drug Abuse estimates that substance use disorders, comprising illicit drugs and alcohol use as well as smoking, cost the United States more than $740 billion per year. This includes the cost of crime, incarceration, lost productivity, and medical care. A recent study considered the economic consequences of heroin use specifically, finding […]

July 24, 2017 Research Highlights

Medications for Opioid Use Disorder: Who is Receiving Which Treatment?

In response to the growing opioid epidemic in the United States, there is an increased focus on expanding evidence-based treatment using medications prescribed for substance use disorder, especially medications that can be prescribed in outpatient settings including buprenorphine and naltrexone. The Surgeon General’s report on facing addiction in America describes substance use disorders as chronic illnesses requiring […]

June 14, 2017 Policy Watch

CHERISH Conference on Substance Use Disorder Treatment Research

In the opening plenary panel of the CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, PhD, Chairman of the Board and […]

June 12, 2017 Policy Watch

Philadelphia Task Force Issues Report on Opioids

The opioid epidemic is a national problem, but solutions may be local. In Philadelphia, the Mayor’s Task Force to Combat the Opioid Epidemic recently released a report with 18 recommendations for a “comprehensive and coordinated plan to reduce opioid use disorder and its associated morbidity and mortality.” The report focuses on Philadelphia, but draws on data […]

May 30, 2017 Research Highlights

The Older Face of the Opioid Epidemic

In a recent report, the CDC tracks drug overdose deaths in the US between 1999-2015.  The trends are not exactly what you might expect. Yes, given the recent press attention to the US opioid epidemic, the rates are predictable in that they are unacceptably high and increasing at a shocking rate. Age-adjusted drug overdose rates increased to 16.3 […]

May 17, 2017 Research Highlights

Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use: Evidence from Medicare and Private Insurers

In 2015, over 20,000 Americans died of an overdose related to prescription pain relievers; approximately 1 person every 26 minutes. A study recently published in the New England Journal of Medicine highlights the correlation between emergency department prescribing practices and long-term prescription pain reliever use in Medicare patients. The research team from the Harvard T. H. Chan School of Public Health […]

Engage with CHERISH

Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.